Lin Li

Title: Lin Li: Innovator in Biotherapeutics

Introduction

Lin Li is a prominent inventor based in Monrovia, California, known for his significant contributions to the field of biotherapeutics. With a total of four patents to his name, he has made remarkable advancements in the development of innovative medical treatments.

Latest Patents

One of Lin Li's latest patents is focused on complementary RNA linked bispecific T-cell engaging antibodies. This invention includes antibodies attached to single-stranded oligoribonucleotides, which can form complexes in vivo through hybridization. For instance, a first antibody bound to a first oligoribonucleotide can bind to a cell surface antigen and subsequently form an antibody complex with a second antibody through complementary base-pairing. This technology holds promise for diagnostic and therapeutic applications, particularly in treating cancer and autoimmune diseases. Another notable patent involves cell penetrating conjugates that enhance the intracellular delivery of non-cell penetrating proteins. These conjugates consist of a protein attached to a phosphorothioate nucleic acid or polymer backbone, which improves their effectiveness in cellular delivery.

Career Highlights

Lin Li has worked with esteemed organizations such as City of Hope and the University of Southern California. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Lin Li has collaborated with notable colleagues, including John E. Shively and Piotr Marek Swiderski. Their combined expertise has furthered the development of innovative solutions in biotherapeutics.

Conclusion

Lin Li's contributions to the field of biotherapeutics through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments and therapies.